2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, R Collins, M Antz, P Cornu, L Desteghe… - Ep …, 2021 - academic.oup.com
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

Postoperative atrial fibrillation: mechanisms, manifestations and management

D Dobrev, M Aguilar, J Heijman, JB Guichard… - Nature Reviews …, 2019 - nature.com
Postoperative atrial fibrillation (POAF) complicates 20–40% of cardiac surgical procedures
and 10–20% of non-cardiac thoracic operations. Typical features include onset at 2–4 days …

[HTML][HTML] Apixaban for stroke prevention in subclinical atrial fibrillation

JS Healey, RD Lopes, CB Granger… - … England Journal of …, 2024 - Mass Medical Soc
Background Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually
be detected only by long-term continuous monitoring with pacemakers or defibrillators …

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation

JG Andrade, M Aguilar, C Atzema, A Bell… - Canadian Journal of …, 2020 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation

TS Potpara, GYH Lip… - Thrombosis and …, 2021 - thieme-connect.com
Atrial fibrillation (AF) is a complex condition requiring holistic management with multiple
treatment decisions about optimal thromboprophylaxis, symptom control (and prevention of …

Screening for atrial fibrillation in the older population: a randomized clinical trial

DJ Gladstone, R Wachter, K Schmalstieg-Bahr… - JAMA …, 2021 - jamanetwork.com
Importance Atrial fibrillation (AF) is a major cause of preventable strokes. Screening
asymptomatic individuals for AF may increase anticoagulant use for stroke prevention …

Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease

BL Abramson, M Al-Omran, SS Anand… - Canadian Journal of …, 2022 - Elsevier
Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …

Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus …

DA Gorog, YX Gue, TF Chao, L Fauchier… - Thrombosis and …, 2022 - thieme-connect.com
While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …

Management of atrial fibrillation in 2021: an updated comparison of the current CCS/CHRS, ESC, and AHA/ACC/HRS guidelines

CC Cheung, S Nattel, L Macle, JG Andrade - Canadian Journal of …, 2021 - Elsevier
Given its complexity, the management of atrial fibrillation (AF) has relied increasingly on
expert guideline recommendations; however, discrepancies between these professional …

Prevalence of left atrial thrombus in anticoagulated patients with atrial fibrillation

A Lurie, J Wang, KJ Hinnegan, WF McIntyre… - Journal of the American …, 2021 - jacc.org
Background The prevalence of left atrial (LA) thrombus in patients with atrial fibrillation (AF)
or atrial flutter (AFL) on guideline-directed anticoagulation is not well known, yet this may …